Jupiter Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Buy |
636,375
+229,324
| +56% | +$4.95M | 0.11% | 206 |
|
|
2025
Q1 | $6.76M | Buy |
+407,051
| New | +$6.76M | 0.06% | 254 |
|
|
2024
Q4 | – | Sell |
-157,457
| Closed | -$2.42M | – | 384 |
|
|
2024
Q3 | $2.42M | Sell |
157,457
-903,383
| -85% | -$13.9M | 0.02% | 313 |
|
|
2024
Q2 | $17.2M | Sell |
1,060,840
-542,934
| -34% | -$8.82M | 0.16% | 175 |
|
|
2024
Q1 | $29.7M | Buy |
1,603,774
+281,410
| +21% | +$5.2M | 0.28% | 119 |
|
|
2023
Q4 | $41.4M | Buy |
1,322,364
+46,148
| +4% | +$1.44M | 0.41% | 69 |
|
|
2023
Q3 | $26.6M | Buy |
1,276,216
+4,932
| +0.4% | +$103K | 0.29% | 99 |
|
|
2023
Q2 | $30.4M | Sell |
1,271,284
-96,317
| -7% | -$2.31M | 0.33% | 82 |
|
|
2023
Q1 | $25.7M | Buy |
1,367,601
+277,629
| +25% | +$5.22M | 0.36% | 91 |
|
|
2022
Q4 | $17.3M | Buy |
1,089,972
+1,012,680
| +1,310% | +$16.1M | 0.25% | 129 |
|
|
2022
Q3 | $1.27M | Buy |
77,292
+12,273
| +19% | +$201K | 0.02% | 381 |
|
|
2022
Q2 | $917K | Buy |
+65,019
| New | +$917K | 0.01% | 440 |
|
|
2020
Q4 | – | Sell |
-116,258
| Closed | -$4.8M | – | 578 |
|
|
2020
Q3 | $4.8M | Buy |
+116,258
| New | +$4.8M | 0.05% | 302 |
|